Daunorubicin (Liposomal)

The liposomal version of Daunorubicin is prescribed to treat advanced Kaposi’s sarcoma, a type of cancer where the patient develops abnormal growths in a variety of body tissues. This type of cancer usually occurs only in people who have AIDS. The medication is injected directly into veins in order to slow the growth of cancer cells throughout the body.

Warnings/Side Effects

This medication can cause serious heart disease. The heart may stop pumping as effectively while on the medication, and the damage to the heart may continue for a month after stopping medication. Patients who have suffered from heart disease in the past should not take the medication, and all patients should have regular EKGs to ensure their heart is functioning appropriately.

Liposomal Daunorubicin is also associated with liver disease. Patients who have severe stomach pain, nausea and vomiting, jaundice, brown urine or tarry stools should contact their doctors immediately.

This medication further compromises the immune system, so patients may suffer from infectious illness while on it.

/* Css */ /* Form */

Free Consultation

Contact Jacoby & Meyers
Dangerous Drug Lawyers

Call us Today 800-977-5614

Have you or your loved one suffered an injury?
Yes No
Was Medical Treatment required for the injury?
Yes No
By submitting this form, I agree to be contacted by an attorney from Jacoby & Meyers or one of it sponsors and I hereby acknowledge that I have read the Terms and Condition and I agree to all of its terms and conditions.

*Required Fields

Dangerous Drugs Listing